Effect of zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-PFT

被引：0
|
作者：
Cauley, Jane A.
Black, Dennis
Boonen, Steven R.
Cummings, Steven
Delmas, Pierre
Eastell, Richard
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Leuven Univ, Ctr Metab Bone Dis, Div Geriatr Med, Louvain, Belgium
[4] Univ Lyon 1, F-69365 Lyon, France
[5] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [21] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-pft
    Delmas, P.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eriksen, E. F.
    Mesenbrink, R.
    Eastell, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [22] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S. R.
    Cosman, F.
    Eastell, R.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S29 - S29
  • [23] New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) : 663 - 668
  • [24] Increased integral bone mineral density (BMD) of the hip with once-yearly zoledronic acid 5 mg (ZOL): Quantitative computed tomography data (QCT) from the horizon-pft trial
    Eastell, R.
    Lang, T.
    Boonen, S.
    Cummings, S.
    Delmas, P. D.
    Cauley, J.
    Horowitz, Z.
    Kerzberg, E.
    Leung, P.
    Man, Z.
    Mesenbrink, P.
    Eriksen, E. F.
    Black, D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S54 - S55
  • [25] Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
    Jacques, Richard M.
    Boonen, Steven
    Cosman, Felicia
    Reid, Ian R.
    Bauer, Douglas C.
    Black, Dennis M.
    Eastell, Richard
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (08) : 1627 - 1634
  • [26] Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON Pivotal Fracture Trial.
    Black, D. M.
    Boonen, S.
    Cauley, J.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Rosario-Jansen, T.
    Caminis, J.
    Zhang, J.
    Hu, H.
    Cummings, S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S16 - S16
  • [27] Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON pivotal fracture trial.
    Black, D. M.
    Boonen, S.
    Cauley, J.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Rosario-Jansen, T.
    Caminis, J.
    Zhang, J.
    Hu, H.
    Cummings, S.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S305 - S305
  • [28] EFFICACY AND SAFETY OF ZOLEDRONIC ACID 5 MG IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: THE HORIZON PREVENTION STUDY
    McClung, Michael R.
    Miller, Paul
    Recknor, Christopher
    Ruzucky, Maryellen
    BucciRechtweg, Christina
    Yu, Sue
    Benhamou, Claude Laurent
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S212 - S213
  • [29] The effect of annual treatment with zoledronic acid 5 mg on bone remodeling: Bone histomorphometry results from the HORIZON-PFT.
    Recker, R. R.
    Boonen, S.
    Garcia, P.
    Supronik, J.
    Peichl, P.
    Black, D.
    Krasnow, J.
    Chiodo, J.
    Gasser, J.
    Eriksens, E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S290 - S290
  • [30] The effect of annual treatment with zoledronic acid 5 mg on bone remodeling: Bone histomorphometry results from the HORIZON-PFT.
    Recker, R. R.
    Boonen, S.
    Garcia, P.
    Supronik, J.
    Peichl, P.
    Black, D.
    Krasnow, J.
    Chiodo, I.
    Gasser, J.
    Eriksen, E.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S305 - S306
12345